Asbestosis and catalase genetic polymorphism

Arhiv za Higijenu Rada i Toksikologiju

Volumn 59, Issue 4, 2008, Pages 233-240

  Franko, Alenka ^a   Dolžan, Vita ^b   Arnerić, Niko ^a   Dodič Fikfak, Metoda ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Asbestos exposure; Causal relationship; Nested case control study; Real time PCR

Indexed keywords

CATALASE; CYTOSINE; THYMINE;

ADULT; ARTICLE; ASBESTOSIS; CASE CONTROL STUDY; CAT 262 GENE; CONTROLLED STUDY; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR;

ASBESTOSIS; CATALASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; POLYMORPHISM, GENETIC;

EID: 57449107390     PISSN: 00041254     EISSN: None     Source Type: Journal    
DOI: 10.2478/10004-1254-59-2008-1907     Document Type: Article

References (41)

1. Peters GA, Peters BJ. Medical aspects. In: Peters GA, Peters BJ, editors. Sourcebook on asbestos diseases: medical, legal, and engineering aspects. New York, London: Gerland STPM Press; 1980. p. B2-B6.
2. th edition. Vol. 2. New York (NY): McGraw Hill; 1987. p. 1069-70.
3. Mossman BT, Bignon J, Corn M, Seaton A, Gee JB. Asbestos: scientific developments and implications for public policy. Science 1990;247:294-301.
4. Mossman BT, Gee JB. Asbestos-related diseases. N Engl J Med 1989;320:1721-30.
5. Dement JM, Brown DP, Okun A. Follow-up study of chrysotile asbestos textile workers: cohort mortality and case-control analyses. Am J Ind Med 1994;26:431-47.
6. Jakobsson K, Strömberg U, Albin M, Welinder H, Hagmar L. Radiological changes in asbestos cement workers. Occup Environ Med 1995;52:20-7.
7. Franko A, Dodic-Fikfak M, Arneric N, Dolzan V. Glutathione S-transferases GSTM1 and GSTT1 polymorphisms and asbestosis. J Occup Environ Med 2007;49:667-71.
8. Jakobsson K, Rannung A, Alexandrie AK, Rylander L, Albin M, Hagmar L. Genetic polymorphism for glutathione-S-transferase mu in asbestos cement workers. Occup Environ Med 1994;51:812-6.
9. Smith CM, Kelsey KT, Wiencke JK, Leyden K, Levin S, Christiani DC. Inherited glutathione-S-transferase deficiency is a risk factor for pulmonary asbestosis. Cancer Epidemiol Biomarkers Prev 1994;3:471-7.
10. Hirvonen A, Saarikoski ST, Linnainmaa K, Koskinen K, Husgafvel-Pursiainen K, Mattson K, Vainio H. Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996;88:1853-6.
11. Kinnula VL. Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres. Eur Respir J 1999;14:706-16.
12. Xu A, Zhou H, Yu DZ, Hei TK. Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. Environ Health Perspect 2002;110:1003-8.
13. Castranova V. Role of nitric oxide in the progression of pneumoconiosis. Biochemistry (Mosc) 2004;69:32-7.
14. Kamp DW, Panduri V, Weitzman SA, Chandel N. Asbestos-induced alveolar epithelial cell apoptosis: role of mitochondrial dysfunction caused by iron-derived free radicals. Mol Cell Biochem 2002;234-235:153-60.
15. Panduri V, Weitzman SA, Chandel N, Kamp DW. The mitochondria-regulated death pathway mediates asbestos-induced alveolar epithelial cell apoptosis. Am J Respir Cell Mol Biol 2003;28:241-8.
16. Poser I, Rahman Q, Lohani M, Yadav S, Becker HH, Weiss DG, Schiffmann D, Dopp E. Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor. Mutat Res 2004;559:19-27.
17. Ding M, Dong Z, Chen F, Pack D, Ma WY, Ye J, Shi X, Castranova V, Vallyathan V. Asbestos induces activator protein-1 transactivation in transgenic mice. Cancer Res 1999;59:1884-9.
18. Weitzman SA, Graceffa P. Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 1984;228:373-6.
19. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992;12:293-315.
20. rd edition. Oxford, New York: Oxford University Press; 1999. p. 430-481.
21. rd edition. Oxford, New York: Oxford University Press; 1999. p. 134-8.
22. Forsberg L, Lyrenäs L, de Faire U, Morgenstern R. A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. Free Radic Biol Med 2001;30:500-5.
23. Ahn J, Nowell S, McCann SE, Yu J, Carter L, Lang NP, Kadlubar FF, Ratnasinghe LD, Ambrosone CB. Associations between catalase phenotype and genotype: modification by epidemiologic factors. Cancer Epidemiol Biomarkers Prev 2006;15:1217-22.
24. Jiang Z, Akey JM, Shi J, Xiong M, Wang Y, Shen Y, Xu X, Chen H, Wu H, Xiao J, Lu D, Huang W, Jin L. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet 2001;109:95-8.
25. Casp CB, She JX, McCormack WT. Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002;15:62-6.
26. Zhou XF, Cui J, DeStefano AL, Chazaro I, Farrer LA, Manolis AJ, Gavras H, Baldwin CT. Polymorphisms in the promoter region of catalase gene and essential hypertension. Dis Markers 2005;21:3-7.
27. Quan F, Korneluk RG, Tropak MB, Gravel RA. Isolation and characterization of the human catalase gene. Nucleic Acids Res 1986;14:5321-35.
28. Nadif R, Mintz M, Jedlicka A, Bertrand JP, Kleeberger SR, Kauffmann F. Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli. Free Radic Res 2005;39:1345-50.
29. Bastaki M, Huen K, Manzanillo P, Chande N, Chen C, Balmes JR, Tager IB, Holland N. Genotype-activity relationship for Mn-superoxide dismutase, glutathione peroxidase 1 and catalase in humans. Pharmacogenet Genomics 2006;16:279-86.
30. Hirvonen A, Tuimala J, Ollikainen T, Linnainmaa K, Kinnula V. Manganese superoxide dismutase genotypes and asbestos-associated pulmonary disorders. Cancer Lett 2002;178:71-4.
31. Franko A, Dolzan V, Arneric N, Dodic-Fikfak M. The influence of genetic polymorphisms of GSTP1 on the development of asbestosis. J Occup Environ Med 2008;50:7-12.
32. Vidan-Jeras B, Jurca B, Dolzan V, Jeras M, Breskvar K, Bohinjec M. Caucasian Slovenian normal. In: Gjertson DW, Terasaki PI, editors. HLA 1998. Lenexa: American Society for Histocompatibility and Immunogenetics; 1998. p. 180-1.
33. Dodic Fikfak M, Kriebel D, Quinn MM, Eisen EA, Wegman DH. A case control study of lung cancer and exposure to chrysotile and amphibole at a Slovenian asbestos-cement plant. Ann Occup Hyg 2007;51:261-8.
34. Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978;118:1-120.
35. Tossavainen A. Asbestos, asbestosis, and cancer: The Helsinki criteria for diagnosis and attribution. Scand J Work Environ Health 1997;23:311-6.
36. American Thoracic Society (ATS). Diagnosis and initial management of nonmalignant diseases related to asbestos. Am J Respir Crit Care Med 2004;170:691-751.
37. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med 2001;249:477-93.
38. Furberg AH, Ambrosone CB. Molecular epidemiology, biomarkers and cancer prevention. Trends Mol Med 2001;7:517-21.
39. Boks MP, Schipper M, Schubart CD, Sommer IE, Kahn RS, Ophoff RA. Investigating gene environment interaction in complex diseases: increasing power by selective sampling for environmental exposure. Int J Epidemiol 2007;36:1363-9.
40. Kelsey KT, Nelson HH, Wiencke JK, Smith CM, Levin S. The glutathione S-transferase theta and mu deletion polymorphisms in asbestosis. Am J Ind Med 1997;31:274-9.
41. Neri M, Ugolini D, Dianzani I, Gemignani F, Landi S, Cesario A, Magnani C, Mutti L, Puntoni R, Bonassi S. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res 2008;659:126-36.